HeartBeat.bio is a drug discovery company focused on developing a high-throughput 3D screening platform for heart failure and cardiomyopathies. Our core technology is based on the worldwide first self-organizing cardiac organoids (Cardioids) which resemble the human physiology of a heart chamber in a way that allows for the cost-efficient and large-scale in vitro analysis of crucial clinical parameters associated with cardiac diseases. We believe the Cardioid platform technology has the potential to revolutionize the current cardiac drug discovery paradigm.
We work in a dynamic and collaborative environment at the Vienna BioCenter (VBC) and are looking for highly motivated candidates that share our excitement for human organoids. Currently, we are seeking a Scientist with a strong interest in disease modeling and associated molecular and functional assays. Since we are a start-up with an agile working environment, we envision the candidate working on multiple core teams at the intersection of disease modeling and assay development.
Have completed a Master’s degree (or equivalent) in the life science fields
Have iPSC or ESC cell culture experience
Be familiar with microscopy techniques
Be familiar with molecular cloning
Experience with gene editing approaches such as CRISPR/Cas9 is beneficial
Experience with cardiac biology and stem cell differentiation is beneficial
Have an interest in high-throughput screening
Have excellent communication and organizational skills
Enjoy working in a high-performance team
Since we are working in an international scientific environment, excellent English is required. German language skills are a plus but not mandatory.
The annual gross salary is € 32,000 or higher depending on qualification and experience for full-time employment (40h/week).
If you’re interested in joining our exciting new company, please send your CV, letter of motivation and, if possible, the names and contact details of two references to Dr. Pablo Hofbauer (email@example.com). Candidates will be evaluated on a rolling basis.
We look forward to hearing from you.
Vienna Biocenter 6
Dr. Bohr Gasse 7